Related Experiment Video
Updated: Jul 14, 2026

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells
1Department of Medicine and Committee on Molecular Metabolism and Nutrition, Division of Biological Sciences, The University of Chicago, Chicago, Illinois 60637, USA.
Abstract:
Macrophages accumulate in kidney glomeruli and interstitium of patients with diabetic nephropathy in response to monocyte chemoattractant protein-1 (MCP-1); a chemokine produced by both tubular epithelial and mesangial cells (MCs). Vitamin D and its analogs have been shown to have renoprotective effects; however, there are few studies involving diabetic nephropathy. We explored mechanisms by which 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) can be renoprotective by measuring MCP-1 expression in MCs. Using a luciferase reporter assay, we found that high glucose (HG)-induced MCP-1 transcription and that this induction is blocked by 1,25(OH)2D3. Electrophoretic mobility shift and chromatin immunoprecipitation assays showed that HG increased the p65/p50 binding to the two NF-kappaB sites within the promoter. This was suppressed by 1,25(OH)2D3, but this decrease was reversed by overexpression of p65. 1,25(OH)2D3 was found to stabilize IkappaBalpha leading to an inhibition of p65 translocation to the nucleus and subsequent reduction of NF-kappaB binding. In primary MCs prepared from vitamin D receptor knockout animals, basal MCP-1 levels were elevated but not affected by 1,25(OH)2D3. The analog paricalcitol inhibited the induction and activity of MCP-1 while ameliorating glomerulosclerosis in streptozotocin-diabetic mice. Our results suggest that 1,25(OH)2D3 might block hyperglycemia-induced renal injury by blunting NF-kappaB activation.
Insights
Vitamin D (1,25(OH)2D3) blocks high glucose-induced kidney injury by inhibiting monocyte chemoattractant protein-1 (MCP-1) production via the NF-kappaB pathway. This suggests a potential therapeutic role for vitamin D in diabetic nephropathy.
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Diabetic nephropathy is characterized by macrophage infiltration in the kidneys, driven by monocyte chemoattractant protein-1 (MCP-1).
- Vitamin D and its analogs possess renoprotective properties, but their specific role in diabetic nephropathy requires further elucidation.
Purpose of the Study:
- To investigate the mechanisms by which 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) exerts renoprotective effects in diabetic nephropathy.
- To assess the impact of 1,25(OH)2D3 on MCP-1 expression and NF-kappaB activation in mesangial cells (MCs).
Main Methods:
- Utilized luciferase reporter assays to measure MCP-1 transcription in response to high glucose and 1,25(OH)2D3.
- Employed electrophoretic mobility shift and chromatin immunoprecipitation assays to analyze NF-kappaB binding and p65/p50 activity.
- Investigated the effect of 1,25(OH)2D3 on IkappaBalpha stabilization and p65 translocation.
- Examined MCP-1 levels in primary MCs from vitamin D receptor knockout mice.
- Evaluated the efficacy of paricalcitol in a mouse model of diabetic nephropathy.
Main Results:
- High glucose significantly increased MCP-1 transcription, an effect inhibited by 1,25(OH)2D3.
- High glucose enhanced p65/p50 binding to NF-kappaB sites, which was suppressed by 1,25(OH)2D3.
- 1,25(OH)2D3 stabilized IkappaBalpha, inhibiting p65 nuclear translocation and NF-kappaB binding.
- Vitamin D receptor knockout MCs showed elevated basal MCP-1 levels, unaffected by 1,25(OH)2D3.
- Paricalcitol reduced MCP-1 induction and activity, ameliorating glomerulosclerosis in diabetic mice.
Conclusions:
- 1,25-dihydroxyvitamin D3 inhibits high glucose-induced MCP-1 production in MCs by suppressing NF-kappaB activation.
- Vitamin D receptor signaling is crucial for the inhibitory effects of 1,25(OH)2D3 on MCP-1.
- These findings suggest that 1,25(OH)2D3 and its analogs may represent a therapeutic strategy for mitigating hyperglycemia-induced renal injury in diabetic nephropathy.
Related Concept Videos
Cell Specific Gene Expression
Insulin Secretory Vesicles
Diabetic Nephropathy
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...